Which has higher earnings & valuation, DXCM or ALGN?

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.91 $836.30M $2.53 33.74 Align Technology $4.03B 2.55 $410.35M $5.75 25.00

Is DXCM or ALGN more profitable?

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 20.12% 35.94% 14.75% Align Technology 9.99% 15.86% 10.32%

Does the media refer more to DXCM or ALGN?

In the previous week, DexCom and DexCom both had 8 articles in the media. DexCom's average media sentiment score of 0.54 beat Align Technology's score of 0.37 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to HQY or ALGN?

In the previous week, Align Technology had 3 more articles in the media than HealthEquity. MarketBeat recorded 8 mentions for Align Technology and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.49 beat Align Technology's score of 0.37 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Align Technology 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HSIC or ALGN?

In the previous week, Align Technology had 3 more articles in the media than Henry Schein. MarketBeat recorded 8 mentions for Align Technology and 5 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.85 beat Align Technology's score of 0.37 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MEDP or ALGN more profitable?

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Align Technology 9.99% 15.86% 10.32%

Does the media refer more to MEDP or ALGN?

In the previous week, Medpace had 17 more articles in the media than Align Technology. MarketBeat recorded 25 mentions for Medpace and 8 mentions for Align Technology. Medpace's average media sentiment score of 0.47 beat Align Technology's score of 0.37 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 8 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Align Technology 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, ALGN or QTRX?

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.03B 2.55 $410.35M $5.75 25.00 Quanterix $138.90M 1.24 -$107.15M -$2.63 N/A

Align Technology (ALGN) Competitors

$143.74 -1.61 (-1.11%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$143.76 +0.02 (+0.02%)

As of 10/2/2026 07:30 PM Eastern

Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? Align Technology's main competitors and comparable companies include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Align Technology compare to DexCom?

DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership.

DexCom has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

97.8% of DexCom shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.3% of DexCom shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, DexCom and DexCom both had 8 articles in the media. DexCom's average media sentiment score of 0.54 beat Align Technology's score of 0.37 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	20.12%	35.94%	14.75%
Align Technology	9.99%	15.86%	10.32%

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.91	$836.30M	$2.53	33.74
Align Technology	$4.03B	2.55	$410.35M	$5.75	25.00

DexCom presently has a consensus price target of $89.74, suggesting a potential upside of 5.13%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 43.56%. Given Align Technology's higher probable upside, analysts clearly believe Align Technology is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	2 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.92
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

DexCom beats Align Technology on 12 of the 16 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

In the previous week, Align Technology had 3 more articles in the media than HealthEquity. MarketBeat recorded 8 mentions for Align Technology and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.49 beat Align Technology's score of 0.37 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HealthEquity currently has a consensus target price of $112.20, suggesting a potential upside of 24.61%. Align Technology has a consensus target price of $206.36, suggesting a potential upside of 43.56%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

HealthEquity has a net margin of 17.36% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Align Technology	9.99%	15.86%	10.32%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.67	$215.20M	$2.77	32.51
Align Technology	$4.03B	2.55	$410.35M	$5.75	25.00

HealthEquity has a beta of 0.24, suggesting that its share price is 76% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Summary

HealthEquity and Align Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

In the previous week, Align Technology had 3 more articles in the media than Henry Schein. MarketBeat recorded 8 mentions for Align Technology and 5 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.85 beat Align Technology's score of 0.37 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Align Technology has a net margin of 9.99% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Align Technology	9.99%	15.86%	10.32%

Henry Schein has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.75
Align Technology	$4.03B	2.55	$410.35M	$5.75	25.00

Henry Schein currently has a consensus price target of $92.93, indicating a potential upside of 9.49%. Align Technology has a consensus price target of $206.36, indicating a potential upside of 43.56%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Align Technology beats Henry Schein on 11 of the 17 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Medpace (NASDAQ:MEDP) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

In the previous week, Medpace had 17 more articles in the media than Align Technology. MarketBeat recorded 25 mentions for Medpace and 8 mentions for Align Technology. Medpace's average media sentiment score of 0.47 beat Align Technology's score of 0.37 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	8 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

78.0% of Medpace shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Medpace currently has a consensus target price of $602.27, indicating a potential upside of 0.47%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 43.56%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Align Technology	9.99%	15.86%	10.32%

Medpace has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.61	$451.12M	$17.06	35.14
Align Technology	$4.03B	2.55	$410.35M	$5.75	25.00

Medpace has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Summary

Medpace beats Align Technology on 10 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Align Technology (NASDAQ:ALGN) and Quanterix (NASDAQ:QTRX) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Align Technology presently has a consensus target price of $206.36, suggesting a potential upside of 43.56%. Quanterix has a consensus target price of $3.00, suggesting a potential downside of 17.58%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Align Technology had 8 more articles in the media than Quanterix. MarketBeat recorded 8 mentions for Align Technology and 0 mentions for Quanterix. Align Technology's average media sentiment score of 0.37 beat Quanterix's score of 0.00 indicating that Align Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Align Technology	Neutral
Quanterix	Neutral

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.55	$410.35M	$5.75	25.00
Quanterix	$138.90M	1.24	-$107.15M	-$2.63	N/A

Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market.

Align Technology has a net margin of 9.99% compared to Quanterix's net margin of -80.25%. Align Technology's return on equity of 15.86% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Quanterix	-80.25%	-26.09%	-19.03%

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Align Technology beats Quanterix on 16 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALGN vs. The Competition

Export

Metric	Align Technology	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$10.29B	$5.48B	$7.15B	$13.28B
Dividend Yield	N/A	1.81%	2.54%	17.33%
P/E Ratio	25.00	25.42	274.71	26.04
Price / Sales	2.55	67.70	656.46	105.16
Price / Cash	12.11	32.27	78.87	52.62
Price / Book	2.55	5.73	10.93	6.31
Net Income	$410.35M	$152.68M	$3.51B	$362.16M
7 Day Performance	-2.07%	-1.71%	-2.00%	-1.66%
1 Month Performance	-9.39%	-4.87%	-6.19%	-4.68%
1 Year Performance	8.75%	1.30%	8.03%	1.57%

Align Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALGN Align Technology	3.8662 of 5 stars	$143.74 -1.1%	$206.36 +43.6%	+8.8%	$10.29B	$4.03B	25.00	20,290	News Coverage
DXCM DexCom	3.6365 of 5 stars	$86.68 +0.1%	$89.08 +2.8%	+27.3%	$32.69B	$4.66B	34.26	11,000	Analyst Forecast Insider Trade
HQY HealthEquity	4.3657 of 5 stars	$88.44 +0.2%	$112.20 +26.9%	+1.6%	$7.30B	$1.31B	31.93	2,814	Analyst Downgrade
HSIC Henry Schein	3.6136 of 5 stars	$85.99 -0.4%	$92.93 +8.1%	+26.6%	$9.63B	$13.18B	25.07	25,000	Positive News
MEDP Medpace	2.3676 of 5 stars	$615.94 -0.5%	$595.20 -3.4%	+12.6%	$17.27B	$2.53B	36.10	6,200	Trending News Analyst Upgrade Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Summary

How does Align Technology compare to HealthEquity?

Summary

How does Align Technology compare to Henry Schein?

Summary

How does Align Technology compare to Medpace?

Summary

How does Align Technology compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Which has more risk and volatility, DXCM or ALGN?

Do insiders & institutionals hold more shares of DXCM or ALGN?

Does the media refer more to DXCM or ALGN?

Is DXCM or ALGN more profitable?

Which has higher earnings & valuation, DXCM or ALGN?

Do analysts recommend DXCM or ALGN?

Summary

How does Align Technology compare to HealthEquity?

Does the media refer more to HQY or ALGN?

Do analysts prefer HQY or ALGN?

Is HQY or ALGN more profitable?

Do institutionals and insiders hold more shares of HQY or ALGN?

Which has preferable valuation & earnings, HQY or ALGN?

Which has more risk & volatility, HQY or ALGN?

Summary

How does Align Technology compare to Henry Schein?

Does the media favor HSIC or ALGN?

Do institutionals and insiders believe in HSIC or ALGN?

Is HSIC or ALGN more profitable?

Which has more risk and volatility, HSIC or ALGN?

Which has higher valuation and earnings, HSIC or ALGN?

Do analysts prefer HSIC or ALGN?

Summary

How does Align Technology compare to Medpace?

Does the media refer more to MEDP or ALGN?

Do insiders and institutionals believe in MEDP or ALGN?

Do analysts rate MEDP or ALGN?

Is MEDP or ALGN more profitable?

Which has preferable valuation & earnings, MEDP or ALGN?

Which has more volatility and risk, MEDP or ALGN?

Summary

How does Align Technology compare to Quanterix?

Do analysts prefer ALGN or QTRX?

Does the media favor ALGN or QTRX?

Which has preferable valuation and earnings, ALGN or QTRX?

Which has more volatility & risk, ALGN or QTRX?

Is ALGN or QTRX more profitable?

Do institutionals & insiders hold more shares of ALGN or QTRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools